Spectral AI (MDAI) Net Cash Flow Growth (3y) (2024 - 2026)
Spectral AI (MDAI) Net Cash Flow Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | -48.90% |
| 10 | Spectral AI | 52.40 Mn | 40.74 Mn | 2.03 Mn | 1.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14% |
| Dec 31, 2025 | -73.07% |
| Sep 30, 2025 | 63.13% |
| Jun 30, 2025 | -145.85% |
| Mar 31, 2025 | 215.08% |
| Dec 31, 2024 | 160.39% |
| Sep 30, 2024 | -765.63% |
| Jun 30, 2024 | -63.31% |
| Mar 31, 2024 | 49.04% |